• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膜性肾病中免疫复合物的命运。

The fate of immune complexes in membranous nephropathy.

机构信息

School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China.

Qi Huang of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.

出版信息

Front Immunol. 2024 Aug 8;15:1441017. doi: 10.3389/fimmu.2024.1441017. eCollection 2024.

DOI:10.3389/fimmu.2024.1441017
PMID:39185424
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11342396/
Abstract

The most characteristic feature of membranous nephropathy (MN) is the presence of subepithelial electron dense deposits and the consequential thickening of the glomerular basement membrane. There have been great advances in the understanding of the destiny of immune complexes in MN by the benefit of experimental models represented by Heymann nephritis. Subepithelial immune complexes are formed by autoantibodies targeting native autoantigens or exogenous planted antigens such as the phospholipase A2 receptor (PLA2R) and cationic BSA respectively. The nascent immune complexes would not be pathogenic until they develop into immune deposits. Podocytes are the major source of autoantigens in idiopathic membranous nephropathy. They also participate in the modulation and removal of the immune complexes to a large extent. The balance between deposition and clearance is regulated by a wide range of factors such as the composition and physicochemical properties of the immune complexes and the complement system. Complement components such as C3 and C1q have been reported to be precipitated with the deposits whereas a complement regulatory protein CR1 expressed by podocytes is involved in the phagocytosis of immune complexes by podocytes. Podocytes regulate the dynamic change of immune complexes which is disturbed in membranous nephropathy. To elucidate the precise fate of the immune complexes is essential for developing more rational and novel therapies for membranous nephropathy.

摘要

膜性肾病(MN)最典型的特征是上皮下电子致密沉积物的存在,以及由此导致的肾小球基底膜增厚。通过实验模型(如 Heymann 肾炎)的受益,人们对 MN 中免疫复合物的命运有了很大的了解。上皮下免疫复合物是由针对天然自身抗原或外源性种植抗原(如磷脂酶 A2 受体(PLA2R)和阳离子 BSA)的自身抗体形成的。新形成的免疫复合物在发展成免疫沉积物之前不会具有致病性。足细胞是特发性膜性肾病中自身抗原的主要来源。它们在很大程度上还参与了免疫复合物的调节和清除。沉积和清除之间的平衡受到多种因素的调节,如免疫复合物的组成和理化性质以及补体系统。已经报道补体成分(如 C3 和 C1q)与沉积物一起沉淀,而由足细胞表达的补体调节蛋白 CR1 则参与了足细胞对免疫复合物的吞噬作用。足细胞调节免疫复合物的动态变化,在膜性肾病中这种变化被打乱。阐明免疫复合物的确切命运对于开发更合理和新颖的膜性肾病治疗方法至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/994a/11342396/de261bad7de2/fimmu-15-1441017-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/994a/11342396/36e17db16ad6/fimmu-15-1441017-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/994a/11342396/de261bad7de2/fimmu-15-1441017-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/994a/11342396/36e17db16ad6/fimmu-15-1441017-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/994a/11342396/de261bad7de2/fimmu-15-1441017-g002.jpg

相似文献

1
The fate of immune complexes in membranous nephropathy.膜性肾病中免疫复合物的命运。
Front Immunol. 2024 Aug 8;15:1441017. doi: 10.3389/fimmu.2024.1441017. eCollection 2024.
2
Immunology of membranous nephropathy: from animal models to humans.膜性肾病的免疫学:从动物模型到人类
Clin Exp Immunol. 2016 Feb;183(2):157-65. doi: 10.1111/cei.12729. Epub 2015 Nov 24.
3
Is primary membranous nephropathy a complement mediated disease?原发性膜性肾病是否为补体介导的疾病?
Mol Immunol. 2020 Dec;128:195-204. doi: 10.1016/j.molimm.2020.10.017. Epub 2020 Nov 1.
4
A Novel Insight into the Role of PLA2R and THSD7A in Membranous Nephropathy.PLA2R 和 THSD7A 在膜性肾病中的作用的新见解。
J Immunol Res. 2021 Jul 14;2021:8163298. doi: 10.1155/2021/8163298. eCollection 2021.
5
Immunological Pathogenesis of Membranous Nephropathy: Focus on PLA2R1 and Its Role.膜性肾病的免疫学发病机制:聚焦 PLA2R1 及其作用。
Front Immunol. 2019 Aug 6;10:1809. doi: 10.3389/fimmu.2019.01809. eCollection 2019.
6
Unmet challenges in membranous nephropathy.膜性肾病的未满足需求挑战。
Curr Opin Nephrol Hypertens. 2019 Jan;28(1):70-76. doi: 10.1097/MNH.0000000000000459.
7
Identification of the immunodominant epitope region in phospholipase A2 receptor-mediating autoantibody binding in idiopathic membranous nephropathy.鉴定特发性膜性肾病中磷脂酶A2受体介导自身抗体结合的免疫显性表位区域。
J Am Soc Nephrol. 2015 Feb;26(2):291-301. doi: 10.1681/ASN.2013121315. Epub 2014 Sep 9.
8
Molecular classification of membranous nephropathy.膜性肾病的分子分类。
Curr Opin Nephrol Hypertens. 2019 Jul;28(4):336-344. doi: 10.1097/MNH.0000000000000516.
9
Management of Membranous Nephropathy in the PLAR Era.PLAR时代膜性肾病的管理
Clin J Am Soc Nephrol. 2018 May 7;13(5):784-786. doi: 10.2215/CJN.12461117. Epub 2018 Jan 29.
10
Membranous Nephropathy and Anti-Podocytes Antibodies: Implications for the Diagnostic Workup and Disease Management.膜性肾病与抗足细胞抗体:对诊断和疾病管理的影响。
Biomed Res Int. 2018 Jan 8;2018:6281054. doi: 10.1155/2018/6281054. eCollection 2018.

引用本文的文献

1
Influencing Factors of Treatment Response to Rituximab in Refractory Membranous Nephropathy.利妥昔单抗治疗难治性膜性肾病疗效的影响因素
Drug Des Devel Ther. 2025 Aug 18;19:7059-7067. doi: 10.2147/DDDT.S538971. eCollection 2025.
2
Shared hub genes in membranous nephropathy and kidney renal clear cell carcinoma: investigating molecular overlap and tumor progression.膜性肾病和肾透明细胞癌中的共享枢纽基因:探究分子重叠与肿瘤进展
Discov Oncol. 2025 Jun 9;16(1):1035. doi: 10.1007/s12672-025-02701-1.

本文引用的文献

1
Autoantibodies against laminin-521 are pathogenic in anti-glomerular basement membrane disease.抗层粘连蛋白-521 自身抗体在抗肾小球基底膜病中具有致病性。
Kidney Int. 2023 Dec;104(6):1124-1134. doi: 10.1016/j.kint.2023.07.023. Epub 2023 Aug 19.
2
Membranous nephropathy: new pathogenic mechanisms and their clinical implications.膜性肾病:新的发病机制及其临床意义。
Nat Rev Nephrol. 2022 Jul;18(7):466-478. doi: 10.1038/s41581-022-00564-1. Epub 2022 Apr 28.
3
Discovery of Autoantibodies Targeting Nephrin in Minimal Change Disease Supports a Novel Autoimmune Etiology.
在微小病变性肾病中发现针对 Nephrin 的自身抗体支持新的自身免疫病因。
J Am Soc Nephrol. 2022 Jan;33(1):238-252. doi: 10.1681/ASN.2021060794. Epub 2021 Nov 3.
4
Glomerular Endothelial Cell-Derived microRNA-192 Regulates Nephronectin Expression in Idiopathic Membranous Glomerulonephritis.肾小球内皮细胞源性 microRNA-192 调节特发性膜性肾小球肾炎中纤连蛋白表达。
J Am Soc Nephrol. 2021 Nov;32(11):2777-2794. doi: 10.1681/ASN.2020121699.
5
Clinical characteristics and outcomes of idiopathic membranous nephropathy with glomerular IgM deposits.特发性膜性肾病伴肾小球 IgM 沉积的临床特征和转归。
Clin Exp Med. 2022 Aug;22(3):455-464. doi: 10.1007/s10238-021-00768-y. Epub 2021 Oct 26.
6
Membranous nephropathy.膜性肾病。
Nat Rev Dis Primers. 2021 Sep 30;7(1):69. doi: 10.1038/s41572-021-00303-z.
7
Immune cell behaviour and dynamics in the kidney - insights from in vivo imaging.肾脏中免疫细胞的行为与动态——来自体内成像的见解
Nat Rev Nephrol. 2022 Jan;18(1):22-37. doi: 10.1038/s41581-021-00481-9. Epub 2021 Sep 23.
8
Advances in Understanding of Pathogenesis and Treatment of Immune-Mediated Kidney Disease: A Review.免疫介导性肾病发病机制和治疗研究进展:综述
Am J Kidney Dis. 2022 Apr;79(4):582-600. doi: 10.1053/j.ajkd.2021.07.019. Epub 2021 Sep 8.
9
The glomerular filtration barrier: a structural target for novel kidney therapies.肾小球滤过屏障:新型肾脏治疗的结构靶点。
Nat Rev Drug Discov. 2021 Oct;20(10):770-788. doi: 10.1038/s41573-021-00242-0. Epub 2021 Jul 14.
10
Membranous Nephropathy With Monoclonal IgM Lambda Deposits in a Patient With IgM Monoclonal Gammopathy: A Case Report.IgM单克隆丙种球蛋白病患者伴单克隆IgMλ沉积的膜性肾病:一例报告
Front Med (Lausanne). 2021 May 25;8:608741. doi: 10.3389/fmed.2021.608741. eCollection 2021.